Riskpilot← Back to searchSign inGet full accessMorphysio AB
ABActiveOrg 5592831720Innebandyvägen 7Hospital activities · NACE 8610Est. 20201 employees
Revenue 2024
SEK 0
EBITDA margin
—
-97% vs 2023
Equity ratio
79.4%
Financial strength
Net profit 2024
SEK 11K
-90% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK 5K | -97% |
| Net profit | SEK 11K | -90% |
| Total assets | SEK 823K | -2% |
| Equity | SEK 654K | +2% |
| Employees | 1 | — |
Legal name
Morphysio AB
Org number
5592831720
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
16 november 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva konsultverksamhet inom hälso- och sjukvård (sluten- och öppenvård). I verksamheten ingår även konsultverksamhet inom medicin och fysioterapi i samband med idrottstävlingar, evenemang och expeditioner samt vaccinationer och utfärdande av vissa medicinska intyg. Bolaget ska bedriva konsultverksamhet vid utbildning inom medicin och fysioterapi. Överskott av kapital kan komma att investeras i värdepapper och därtill associerade finansiella instrument, fordon och fastigheter.
Address
Innebandyvägen 7
Email
doktor.ohlen@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 1 436 | 1 743 | 1 011 | 0 |
| Staff expenses | — | −1 096 | −622 | −14 |
| EBITDA | 370 | 363 | 187 | 5 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 370 | 363 | 187 | 5 |
| Net financials | — | −2 | 10 | 11 |
| Profit before tax | 367 | 270 | 147 | 16 |
| Tax | −80 | −56 | −32 | −4 |
| Net profit | 287 | 214 | 115 | 11 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 793 | 1 005 | 840 | 823 |
| Equity | 312 | 527 | 642 | 654 |
| Long-term debt | 62 | 1 | 0 | — |
| Short-term debt | 419 | 387 | 57 | 30 |
| Total debt | 481 | 388 | 57 | 30 |
EBITDA margin
533100.0%
This company
15.8%
Market median
+3373951% vs market
20212024
Equity ratio
79.4%
This company
38.2%
Market median
+108% vs market
20212024
Return on equity
1.8%
This company
18.4%
Market median
-90% vs market
20212024
Net profit margin
1144900.0%
This company
8.1%
Market median
+14134468% vs market
20212024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2021 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Morphysio AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Jakob Lindquist | Deputy Board Member | 0 companies |
| Marie Lucia Elisabeth Flink | Deputy Board Member | 0 companies |
| Torbjörn Nordberg | Board of Directors | 0 companies |
| Inga-Lill Elisabeth Flink | Board of Directors | 0 companies |
| Kjell David Ohlén | Board of Directors | 0 companies |